Position in DTIL
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$12,265,979
+$3,369,391 QoQ
Shares Held
2,230,178
+4.3% QoQ
Ownership
8.64%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 78 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,721,223,490 across 84 Biotechnology names. DTIL ranks #43 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 4 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 5 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
2,318,890 | $50,459,046 |
All Filings in DTIL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,265,979 | 2,230,178 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $8,896,588 | 2,138,603 | Shares | Defined | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||